P21

What it is (in plain language)
- It's a 'fertiliser' for the brain. While other nootropics only help current neurons to function better, P21 helps to create new ones. It mimics the effects of the brain's natural growth factors, improving memory, learning and general cognitive health.

Why do you appear online so much
- It is considered an elite nootropic. It is sought after by those who want to reverse cognitive decline or achieve higher levels of information retention and focus, and is far superior to common stimulants because it treats the structure of the brain.

How it is framed today (pragmatic view)
- 1) Evidence: Solid in models of neurodegenerative diseases (Alzheimer's). 2) Objective: Cognitive enhancement and neuronal repair. 3) Risk: As it is a potent neurotrophic peptide, use should be cycled to avoid over-stimulation.

How to use this form
- Read about 'Neurogenesis' in the scientific references section to understand the impact on the hippocampus.

- Quick profile (curated by Subject 157)
- Class: Nootropic
- Status: Verified
- Use case: Cognition
- Route: Nasal
- Tags: Nasal|Injectable|Brain
- Half-life: ~4 Hours
- Start: Variable
- Duration: Cumulative

- Mechanism (high level)
Ciliary Neurotrophic Factor (CNTF) mimic. Neutralises anti-CNTF antibodies and promotes neurogenesis in the hippocampus (DG) and subventricular zone.

- Evidence (what the literature covers)
RANGE OF RESEARCH (Pre-clinical, Non-prescriptive):
Promising studies in Alzheimer's models.
Level of Evidence: C.

- Safety and harm-reduction (non-prescriptive)
Risks: Temporary fatigue (reported).
Initial brain fog.
Cost.
Interactions: Unknown.

- References (anchors)
- Kazim, S. F. (2014) - P21 peptide & neurogenesis - https://doi.org/10.1371/journal.pone.0099007
- PubMed:24896541

Note: Educational/research content. Does not constitute medical advice, diagnosis or prescription.